Fred Alger Management’s Acceleron Pharma XLRN Stock Holding History

Fred Alger Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,091	Closed	-$907K	–	524
2020 Q4	$907K	Sell	7,091 -160	-2%	-$18.8K	﹤0.01%	375
2020 Q3	$816K	Sell	7,251 -4,749	-40%	-$473K	﹤0.01%	359
2020 Q2	$1.14M	Buy	12,000 +2,000	+20%	+$193K	﹤0.01%	340
2020 Q1	$899K	Buy	+10,000	New	+$777K	﹤0.01%	327
2019 Q2	–	Sell	-24,000	Closed	-$1.12M	–	573
2019 Q1	$1.12M	Buy	+24,000	New	+$1.05M	﹤0.01%	323
2016 Q1	–	Sell	-5,700	Closed	-$278K	–	619
2015 Q4	$278K	Buy	+5,700	New	+$205K	﹤0.01%	457

Other funds holding XLRN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fred Alger Management's XLRN Position: Q1 2021 in Review

Fred Alger Management sold out of Acceleron Pharma (XLRN) in Q1 2021, closing a stake of 7,091 shares — an estimated $907K sold.

Fred Alger Management first reported a position in XLRN in Q4 2015 and held it in 6 quarters. The position peaked at $1.14M in Q2 2020. 256 funds tracked by Wall St. Rank hold XLRN as of Q1 2021.

Fred Alger Management reported no remaining Acceleron Pharma position as of Q1 2021 after selling out during the quarter.
Fred Alger Management sold 7,091 Acceleron Pharma shares in Q1 2021, an estimated $907K.
Fred Alger Management first reported a position in Acceleron Pharma in Q4 2015 and held it in 6 quarters.
Fred Alger Management's Acceleron Pharma position peaked at $1.14M in Q2 2020.
256 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2021.

Based on Fred Alger Management's 13F filing for Q1 2021, filed 17 May 2021.